Greenbank Portfolio Company’s Extraordinary Covid-Killing Product Achieves Outstanding International Standard Results And Is Now Installed At London’s Royal Opera House

Toronto, Ontario, May 31, 2021 – GreenBank Capital Inc. (CSE: GBC and OTCMKTS: GRNBF and FRA: 2TL) (“GreenBank” or “the Company”) is thrilled to announce that tests carried out to ISO standards by a leading independent laboratory have confirmed that CodiKoat’s first product that uses its world-leading technology is dramatically effective in killing the Covid-19 virus. […]

Read More…


GreenBank Capital to acquire significant stake in globally important COVID-killer

This news release is not for distribution or dissemination in the United States of America Toronto, Ontario, May 4, 2021 – GreenBank Capital Inc. (CSE: GBC and OTCMKTS: GRNBF and FRA: 2TL) (“GreenBank” or “the Company”) is exceptionally pleased to announce that it has reached agreement to acquire a significant stake in CodiKoat, the UK-based producer […]

Read More…